{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:24Z","timestamp":1786119144804,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/mlr.0b013e3180642f69","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:50:38Z","timestamp":1236192638000},"page":"S23-S28","source":"Crossref","is-referenced-by-count":43,"title":["Improving Depiction of Benefits and Harms"],"prefix":"10.1097","volume":"45","author":[{"given":"Artyom","family":"Sedrakyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuck","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1001\/jama.292.20.2516","article-title":"Shared medical decision making: problems, process, progress.","volume":"292","author":"McNutt","year":"2004","journal-title":"JAMA"},{"key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment.","volume":"318","author":"Laupacis","year":"1988","journal-title":"N Engl J Med"},{"key":"R4-7-20210211","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect.","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archinte.165.10.1140","article-title":"Decisions on drug therapies by numbers needed to treat: a randomized trial.","volume":"165","author":"Halvorsen","year":"2005","journal-title":"Arch Intern Med"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1046\/j.1525-1497.2003.21102.x","article-title":"A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats.","volume":"18","author":"Sheridan","year":"2003","journal-title":"J Gen Intern Med"},{"key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMe058111","article-title":"Benign breast disease\u2014the risks of communicating risk [comments].","volume":"353","author":"Elmore","year":"2005","journal-title":"N Engl J Med"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.327.7417.741","article-title":"Simple tools for understanding risks: from innumeracy to insight.","volume":"327","author":"Gigerenzer","year":"2003","journal-title":"BMJ"},{"key":"R9-7-20210211","article-title":"Reckoning With Risk. 1st ed.","author":"Gigerenzer","year":"2002"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0010-7824(98)00019-5","article-title":"Hormonal contraception and risk of cardiovascular disease. An international perspective.","volume":"57","author":"Farley","year":"1998","journal-title":"Contraception"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis.","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(84)92354-7","article-title":"Phenylpropanolamine and cerebral haemorrhage.","volume":"1","author":"Jick","year":"1984","journal-title":"Lancet"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke.","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women's Health Initiative clinical trial and observational study.","volume":"19","year":"1998","journal-title":"Control Clin Trials"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bmj.38331.655347.8F","article-title":"Association between hormone replacement therapy and subsequent stroke: a meta-analysis [review].","volume":"330","author":"Bath","year":"2005","journal-title":"BMJ"},{"key":"R21-7-20210211","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.38125.465579.55","article-title":"Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.","volume":"329","author":"Lee","year":"2004","journal-title":"BMJ"},{"key":"R22-7-20210211","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.","volume":"64","author":"Brodaty","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R23-7-20210211","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","article-title":"Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.","volume":"363","author":"Hacke","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"R24-7-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European stroke prevention study, part 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"R26-7-20210211","first-page":"982","article-title":"Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen\/progestin interventions trial.","volume":"92","author":"Greendale","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R27-7-20210211","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1525-1497.1999.09028.x","article-title":"Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy.","volume":"14","author":"Nikolajevic-Sarunac","year":"1999","journal-title":"J Gen Intern Med"},{"key":"R28-7-20210211","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer.","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"R29-7-20210211","doi-asserted-by":"crossref","first-page":"916","DOI":"10.7326\/0003-4819-117-11-916","article-title":"Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?","volume":"117","author":"Naylor","year":"1992","journal-title":"Ann Intern Med"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MLR.0b013e3180642f69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:36:13Z","timestamp":1786037773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005650-200710002-00007"}},"subtitle":["Analyses of Studies of Well-Known Therapeutics and Review of High-Impact Medical Journals"],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mlr.0b013e3180642f69","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}